Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Materials & Tools for Developing POC & Rapid Dx 2023

Martyn Boutelle's Biography



Martyn Boutelle, Professor of Biomedical Sensors Engineering, Imperial College London

Martyn Boutelle is Professor of Biomedical Sensors Engineering in the Department of Bioengineering, Imperial College London, and Associate Provost for Estates Planning for Imperial College.
His research group is multidisciplinary comprising, bioengineers, scientists, and clinicians. He develops novel analytical science methods using microfluidics, electrochemical sensors / biosensors, and wireless electronics to make portable (sometimes wearable) monitoring devices for use as point of care devices that typically giving continuous real -time displays. He then uses these in a program of clinical science research focusing on the acute traumatic brain injury including that caused by cardiac arrest, neonatal continuous monitoring and kidney transplantation monitoring. He runs the EPSRC funded Bio-nanofabrication suite designed to make microfluidic and biosensor biosensors using scalable methods to allow use in proof-of-concept clinical trials.

Martyn is past president of the International Society for Monitoring Molecules in Neuroscience, and a founder of the COSBID organization for studying acute human brain injury. He published > 190 papers, chapters and patents. He obtained a BSc and PhD in Chemistry from Imperial College and worked as an EP Abraham Research Fellow in the University of Oxford.

Martyn Boutelle Image

Point of Care Diagnostics – The Opportunity For Real-Time POC Using Microfluidic Sensors and Biosensors

Thursday, 30 November 2023 at 14:00

Add to Calendar ▼2023-11-30 14:00:002023-11-30 15:00:00Europe/LondonPoint of Care Diagnostics – The Opportunity For Real-Time POC Using Microfluidic Sensors and BiosensorsMaterials and Tools for Developing POC and Rapid Dx 2023 in Laguna Hills, CaliforniaLaguna Hills, CaliforniaSELECTBIOenquiries@selectbiosciences.com

The concentration of biomarker molecules can give important information about the health of a person as they are dynamically challenged by acute illness or for example during clinical treatment. Our view is that to do such monitoring effectively ideally requires moment-by-moment measurement of blood or tissue concentrations as this allows treatments to be guided in a personalized way by such data. We have been developing a range of sensing and biosensing solutions for the invasive, minimally invasive, and non-invasive monitoring of people in health care situations. Microfluidics provide a valuable means of clinical sampling and robust quantification of measured signals. I will describe the key challenges in the development of such integrated sensing devices and  present our recent data obtained during models of cardiac arrest and from the neonatal intensive care unit.


Add to Calendar ▼2023-11-28 00:00:002023-11-30 00:00:00Europe/LondonMaterials and Tools for Developing POC and Rapid Dx 2023Materials and Tools for Developing POC and Rapid Dx 2023 in Laguna Hills, CaliforniaLaguna Hills, CaliforniaSELECTBIOenquiries@selectbiosciences.com